An overview of clinical trials in South Africa during COVID-19,
Featuring keynote speaker Professor Salim S. Abdool Karim, FRS
Sponsored by Biocair, the South African Clinical Research Association (SACRA) is delighted to host an interactive webinar focusing on clinical trials in South Africa during COVID-19.
The webinar will take place between 11:30 – 14:00 (SAST / CET) on Wednesday 20 May 2020.
The keynote speaker will be Professor Salim S. Abdool Karim, FRS, South Africa’s Chair of the Government’s Ministerial Advisory Committee.
Professor Abdool Karim’s keynote speech will provide an overview of the current COVID-19 situation in South Africa, including updates and suggestions for tackling the pandemic.
In addition, Professor Abdool Karim will discuss how we can ensure the continuation of non-COVID-19 clinical trials and advancing drug development.
The webinar will take place on International Clinical Trials Day, Wednesday 20 May 2020, and will be the first in a series of events organised by SACRA.
The event series, sponsored by Biocair, aims to increase global awareness of the important role South Africa plays in the advancement of drug development and clinical trials.
To register for the webinar please click here.
Agenda
Wednesday 20 May 11:30 – 14:00, SAST & CET / 10:30 - 13:00 GMT
Webinar Organiser: SACRA Webinar Sponsor: Biocair
11:30 – 11:35: Introduction (SACRA)
11:35 – 12:35: Keynote Presentation With Q&A: Professor Salim S. Abdool Karim, FRS.
• Current situation of COVID-19 in South Africa and update on what system changes need to be in place to deal with COVID-19 going forward.
• How do we ensure that non-COVID clinical trials will continue over the next 18 or so months without interruption, and the adjustment we may have to make to ensure the continuity of drug development?
12:35 – 13:00: SA Clinical trials - stakeholders’ experience in management of studies during COVID-19 (SACRA)
13:00 – 13:25: The role a specialist courier plays in the global life sciences supply chain (Leonard Lazarus, Africa Regional Director, Biocair)
13:25 – 13:45: Q&A
13:45 – 14:00: Summary & Close (SACRA)
The following pre-recorded sessions will be added after the webinar ends as part of an awareness campaign for International Clinical Trials Day and SACRA.
The sessions are:
Nyeleti Mthombeni: South Africa Leading the Way in Medicine Development through Clinical Trials.
TASK Applied Sciences: Running A COVID-19 BCG Vaccine Trial.
Professor Salim S. Abdool Karim, FRS, is a South African clinical infectious diseases epidemiologist who is widely recognized for his scientific contributions to HIV prevention and treatment. He is Director of the Centre for the AIDS Program of Research in South Africa (CAPRISA) and Professor of Global Health in Epidemiology at Columbia University. He is also Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal, South Africa and Associate Member of The Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard University. He has adjunct professorships at Cornell and Harvard universities. He has served as the President of the South African Medical Research Council and is currently serving as the Chair of the South African Ministerial Advisory Committee on COVID-19.
Prof Abdool Karim, FRS is ranked among the World’s most cited scientists by Web of Science. He serves on the Boards of several journals, including the New England Journal of Medicine, Lancet Global Health, Lancet HIV and mBio. He is the Chair of the UNAIDS Scientific Expert Panel, WHO’s HIV Strategic and Technical Advisory Committee as well as the WHO TB-HIV Task Force and is a member of the Scientific Advisory Board for Global Health at the Bill and Melinda Gates Foundation.
His many awards include the African Union’s “Kwame Nkrumah Award”, the most prestigious scientific award in Africa and the Canadian Gairdner Award.
He is a Fellow of the Royal Society and member of the US National Academy of Medicine, the American Academy of Microbiology and the Association of American Physicians.